Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality.

Area of Science:

• Cardiology
• Critical Care Medicine
• Hemodynamics

Background:

• Cardiogenic shock (CS) has a high mortality rate, often exacerbated by vasodilation beyond inadequate cardiac output.
• Understanding the prevalence and impact of vasodilation in severe CS is critical for improving patient survival.

Purpose of the Study:

• To investigate the occurrence of vasodilation in patients with cardiogenic shock.
• To determine the association between vasodilation and mortality in CS patients.

Main Methods:

• Retrospective analysis of 713 CS patients (stages B-E) without sepsis or recent cardiac surgery.
• Vasodilation defined by low systemic vascular resistance (SVR), high norepinephrine equivalent dose, or blunted SVR response to pressors.
• 14-day mortality assessed using multivariable-adjusted Cox models, with SVR thresholds identified via spline models.

Main Results:

• 38% of CS patients exhibited vasodilation, with a 14-day mortality rate of 28%.
• Lower SVR (<800 dynes•s•cm^-5), higher pressor doses, and blunted pressor response were independently linked to increased mortality.
• A blunted pressor response nearly doubled the risk of death (aHR, 1.74).

Conclusions:

• Pathophysiologic vasodilation is a significant and prevalent factor in CS, independently increasing mortality risk.
• Key indicators for CS vasodilation include SVR <800 dynes•s•cm^-5, elevated pressor requirements, or a diminished pressor response.
• Further research into the mechanisms and therapeutic strategies for CS-associated vasodilation is warranted.